pamidronate has been researched along with tamoxifen in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| De Conno, F; Fulfaro, F; Laffranchi, A; Moliterni, A; Polastri, D; Ripamonti, C | 1 |
| Costello, S; Glück, S; Heffernan, M; Hortobagyi, GN; Kennedy, I; Knight, RD; Leff, R; Lipton, A; Mellars, K; Reitsma, DJ; Seaman, JJ; Simeone, J; Stewart, JF; Theriault, RL | 1 |
| Jelic, S; Mitrović, L; Nikolic-Tomasević, Z; Popov, I; Radosavljević, D | 1 |
| Brenner, W; Czech, N; Henze, E; Kampen, WU; Massoudi, S | 1 |
| Johnston, SR | 1 |
| Inaba, M; Kawasaki, I; Nakatsuka, K; Nishizawa, Y; Shoji, T; Yokoyama, H | 1 |
| Chabert, P; Dieny, A; Grimonpont, A; Hadjseyd, M; Mechin-Cretinon, I; Mohseni, H; Truong, P | 1 |
| Haritoglou, C; Mueller, AJ | 1 |
| Rincon, M; Saenger, P | 1 |
| Aglietta, M; Cirillo, S; Gatti, M; Martincich, L; Montemurro, F; Regge, D; Russo, F | 1 |
| Chehal, A; Fuleihan, Gel-H; Mahfoud, Z; Mourad, YA; Salamoun, M; Salem, Z; Shamseddine, A | 1 |
2 review(s) available for pamidronate and tamoxifen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Systemic treatment of metastatic breast cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Pamidronate; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
2 trial(s) available for pamidronate and tamoxifen
| Article | Year |
|---|---|
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Diseases; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Megestrol; Middle Aged; Neoplasm Metastasis; Pamidronate; Tamoxifen | 1999 |
Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcifediol; Diphosphonates; Double-Blind Method; Female; Humans; Neoplasm Staging; Osteoporosis, Postmenopausal; Pamidronate; Placebos; Premenopause; Tamoxifen | 2005 |
12 other study(ies) available for pamidronate and tamoxifen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Pain relief and sclerosis of bone metastases in a patient with breast cancer treated with tamoxifen, radiotherapy and pamidronate disodium: which treatment helped?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Pain Management; Pamidronate; Sclerosis; Tamoxifen; Treatment Outcome | 1998 |
Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Calcium; Diphosphonates; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Hypercalcemia; Middle Aged; Pamidronate; Survival Analysis; Tamoxifen; Time Factors; Treatment Outcome | 2001 |
[Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Lymphatic Metastasis; Middle Aged; Pamidronate; Radionuclide Imaging; Tamoxifen | 2001 |
[Intravenous pamidronate delivery to a case with multiple bone metastasis of breast cancer].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Infusions, Intravenous; Pamidronate; Quality of Life; Radionuclide Imaging; Tamoxifen | 2001 |
[Uterine and ovarian metastases 28 years after the discovery of breast cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Biopsy; Breast Neoplasms; Carcinoma, Lobular; Diphosphonates; Female; Humans; Hysterectomy; Hysteroscopy; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Pamidronate; Tamoxifen; Time Factors; Uterine Neoplasms | 2003 |
[Regression of an uveal metastatic tumor from breast cancer during chemotherapy--a case report].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diphosphonates; Docetaxel; Doxorubicin; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Paclitaxel; Pamidronate; Tamoxifen; Taxoids; Time Factors; Ultrasonography; Visual Acuity | 2003 |
Precocious puberty: McCune-Albright syndrome and beyond.
Topics: Anti-Inflammatory Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Diphosphonates; Estrogen Antagonists; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Heterotrimeric GTP-Binding Proteins; Humans; Male; Menarche; Pamidronate; Puberty, Precocious; Tamoxifen | 2003 |
Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.
Topics: Adult; Aged; Anastrozole; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Goserelin; Humans; Imidazoles; Letrozole; Magnetic Resonance Imaging; Middle Aged; Nitriles; Pamidronate; Pilot Projects; Prospective Studies; Tamoxifen; Triazoles; Zoledronic Acid | 2004 |